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Macrocyclic scaﬀolds are particularly attractive for designing selective G-quadruplex ligands essentially because, on one hand,
they show a poor aﬃnity for the “standard” B-DNA conformation and, on the other hand, they fit nicely with the external
G-quartets of quadruplexes. Stimulated by the pioneering studies on the cationic porphyrin TMPyP4 and the natural product
telomestatin, follow-up studies have developed, rapidly leading to a large diversity of macrocyclic structures with remarkable-
quadruplex binding properties and biological activities. In this review we summarize the current state of the art in detailing the
three main categories of quadruplex-binding macrocycles described so far (telomestatin-like polyheteroarenes, porphyrins and
derivatives, polyammonium cyclophanes), and in addressing both synthetic issues and biological aspects.
1. Introduction
G-rich DNA strands are naturally involved in duplex-DNA
architecture through association with their complementary
C-rich DNA strands by the canonical Watson-Crick pairing
[1–3]. However, a growing body of evidence currently
testifies that this canonical association is not the unique
mode of stabilization of G-rich DNA in cells. Indeed, given
that four guanine residues can self-associate in a planar
arrangement through a Hoogsteen-type hydrogen-bonding
network [4] to form a structure called G-quartet, G-rich
strands can adopt a peculiar three-dimensional arrangement
called G-quadruplex DNA [5–9] resulting from the stacking
of several contiguous G-quartets (Figure 1).
The formation of G-quadruplex DNA is easily conceiv-
able in DNA sequences that are present as single strands
in cells, such as the telomeric overhang. The structural
and functional integrity of this overhang is based on its
association with a constellation of specific proteins, some
of them belonging to the shelterin complex [10]. Alto-
gether, this nucleoproteic assembly caps the chromosomes,
protects their integrity, and is also deeply involved in the
telomeric replication process [11–13]. Numerous studies
currently suggest that quadruplex formation in this overhang
alters the structure and function of telomeres, inducing
a damage response and rapid apoptosis in particular in
cancer cells [14–24]. Thus, over the past decade telomeric G-
quadruplex DNA has been thoroughly studied with an initial
focus on the possible interferences with telomerase activity
[25].
The existence of G-quadruplex DNA is also heavily
implied in the promoter region of genes and oncogenes, and
is thus assumed to play an important regulatory role in their
transcription [26]. It has been indeed demonstrated that the
involvement of G-rich sequences in duplex architecture is
compatible with their folding into quadruplex structures,
thanks to the breathing of duplex DNA [27]. Nevertheless,
we have to keep in mind that these G-quadruplex-forming
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Figure 1: Schematic representation of the folding of an oligonucleotide that mimics the human telomeric sequence (d[AG3(T2AG3)3]).
The polymorphism of the quadruplex is represented through the various possible structures, namely, the hybrid (left), antiparallel (centre),
and parallel (right) forms; these structures diﬀer by strand orientation (grey dashed arrows) and loop arrangement (represented in orange,
yellow, and red).
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Figure 2: Chemical structures of telomestatin and TMPyP4 (with
p-CH3(C6H4)SO3
− as counterions).
sequences although transiently single-stranded are a priori
not as easily accessible as the telomeric sequences, due to the
presence of the transcription machinery [28].
Stabilization of quadruplex architecture by small mol-
ecules is thus emerging as a potential anticancer approach
since it is thought to interfere with oncogenic expression and
telomeric maintenance in cancer cells [11–13]. Interestingly,
several classes of small molecules have been developed
that eﬃciently target G-quadruplex DNA [29–32]. Among
them, macrocycles rapidly became popular for recognition
of quadruplexes motivated by the fact that telomestatin
is one of the most active known G-quadruplex ligands
[33]. This natural 8-ring 24-membered macroheterocycle
(Figure 2) displays high aﬃnity for quadruplex and most
importantly has no aﬃnity for duplex DNA (vide infra).
Nevertheless, apart from several reports on telomestatin-
like molecules, true polyheteroaryl analogues are still scarce,
essentially because of the diﬃculty to synthesise such
molecules. Another well-known G-quadruplex ligand—and
arguably one of the most studied—is TMPyP4 [34, 35], a
tetramethylpyridinium porphyrin (Figure 2). This molecule
has been widely used, essentially due to its great aﬃnity
for several quadruplex targets, as well as its commercial
availability. However, the interest in employing TMPyP4
is somewhat counterbalanced by its lack of quadruplex
selectivity (vide infra).
These two examples illustrate the main reasons that made
the macrocyclic scaﬀold particularly interesting for targeting
G-quadruplex DNA: (i) a broad aromatic surface that favours
the stacking interactions with the external G-quartets of
the quadruplex, (ii) a rigid structure that maximizes the
quartet overlap and, combined with their large size, impedes
intercalation into duplex DNA, and (iii) in the case of
TMPyP4, a cationic charge that promotes the electrostatic
interactions with the negatively charged biopolymer. Unfor-
tunately, the high cationic charge of TMPyP4 represents
both an advantage and a drawback due to the nonspecificity
of electrostatic interactions which promote association with
any form of DNA, but in particular duplex DNA, thereby
decreasing the binding selectivity (vide infra).
A great deal of research eﬀort around the macrocyclic
scaﬀold was thus motivated by these two examples. The
macrocyclic systems described up to now as G-quadruplex
ligands can be divided in three diﬀerent categories: (i)
telomestatin like (i.e., neutral and rigid macrocycles), (ii)
porphyrin (TMPyP4) like (i.e., cationic and rigid macrocy-
cles), and (iii) the less studied family of flexible polyammo-
nium macrocycles (i.e., cationic and non planar), which will
be described herein also in the companion paper, “One Ring
to Bind Them All”—Part II, by A. Granzhan et al.) in the
present issue.
2. Telomestatin-Like Macrocycles
Telomestatin is the benchmark compound in terms of G-
quadruplex recognition (Figure 2). This natural compound
was isolated from Streptomyces anulatus in 2001 by Shin-
ya’s group [33], and has been extensively studied due to
its outstanding selectivity for G-quadruplex and highly
promising biological properties.
One general method to quantify the DNA aﬃnity
of a given molecule is to perform thermal denaturation
experiments, either in a UV-monitored melting assay [36]
or in the so-called “FRET-melting” assay. Here the thermal
unfolding of the quadruplex-forming oligonucleotide
F21T (FAM-G3[T2AG3]3-Tamra), doubly labelled with a
complementary pair of FRET donor and acceptor (FAM:
6-carboxyfluorescein and Tamra: 6-carboxytetramethylrho-
damine), is monitored via FRET (fluorescence resonance
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Figure 3: Qualitative in silico superposition of telomestatin and
a G-tetrad (extracted from PDB entry: 2A5R); guanine residues
appear in gold; the carbon, nitrogen, oxygen, sulphur, and hydrogen
atoms of telomestatin appear in grey, blue, red, yellow, and white,
respectively.
energy transfer) [37]. Semiquantitative evaluation of ligand-
binding aﬃnity is obtained by measuring the increase
in melting temperature induced by the ligand (ΔT1/2).
The quadruplex-over-duplex-DNA selectivity may then
be established via competitive FRET melting which is
carried out in presence of competitive duplex DNA (ds26).
In the presence of telomestatin, the increase in melting
temperature is very large (ΔT1/2 = 24◦C), and since this value
is unaﬀected by the presence of up to 50 equiv. of competitive
duplex DNA (herein ds26, the self-complementary sequence
5′-CA2TCG2ATCGA2T2CGATC2GAT2G-3′), telomestatin
stands among the most selective of G-quadruplex ligands.
This property has been subsequently confirmed by in-
dependent studies using various evaluation techniques.
The enthusiasm for telomestatin was also justified by
its ability to inhibit telomerase [38], with the reported IC50
value lying, impressively, in the nanomolar range (IC50-
TRAP = 5 nM) [33]. However, the relationship between
TRAP assay and telomerase inhibition was recently chal-
lenged on the grounds that this assay does not actually
reflect the influence of the ligand on the activity of the
enzyme but rather the ability of the ligand to inhibit the PCR
amplification step [25]. The direct assay, a more constraining
method based on the telomerase elongation of a telomeric
primer with incorporation of [α-32P]dGTP, provides a more
reliable estimation of the telomerase inhibition ability [25].
Interestingly, telomestatin is still highly active, staying
among the best reported inhibitors, with an IC50 value of
58 nM.
The structure of telomestatin is quite unusual since it
is a neutral polycyclic compound, composed of five oxazole,
two methyloxazole, and one thiazoline rings, whose overall
flatness is impeded by the presence of an sp3 carbon within
the thiazoline ring (Figure 2). Whether this molecule is
aggregated in water is yet not known; however, it is likely
that the strong hydrophobic character of the molecule should
reinforce the hydrophobic forces that contribute to stacking
interactions, and so explain its exceptional eﬀectiveness in
binding G-quadruplex. This eﬃciency is also assumed to rely
on a perfect shape adaptation between the macrocycle and a
G-quartet (Figure 3) [39].
Abundant biophysical and biological investigations have
been performed with telomestatin. For example, it exhibits
an antiproliferative activity against a wide variety of cancer
cell lines with IC50 values between 0.1 and 5 μM, including
human pancreatic carcinoma [40], myeloid leukaemia [41,
42], breast cancer [43], cervical [43], tumoral HT1080 [44],
telomerase-transformed SW39 [45], ALT-transformed SW26
[45], immortalized EcR293 [46], and a panel of myeloma
[47] and neuroblastoma lines [48]. Remarkably, telomes-
tatin does not aﬀect normal cell lines, with no eﬀect observed
at 5 μM on fibroblast MRC-5 cells [43]. This observation has
recently been substantiated by the finding that telomestatin
does not interfere with telomere replication in normal cells
[49]. Telomestatin was also a tool of choice to investigate the
biological role of G-quadruplex ligands in cells by suggesting
that eﬀects of ligands might originate essentially from
the disruption of the telomeric structure with subsequent
displacement of protective proteins (shelterin complex)
rather than in telomerase inhibition [44, 46]. Telomestatin
was used to investigate the role of putative quadruplex
formation within the promoter region of genes like VEGF
[50] and hTERT [51] or oncogenes like c-Myc [52], Bcl-
2 [53], and RET [54], whose corresponding proteins are
overexpressed in some cancers. Recently, telomestatin was
shown to interfere with the ability of helicases to unwind
G-quadruplex structures [55], and to aﬀect the growth
of telomerase-negative ALT (Alternative Lengthening of
Telomeres) cell lines via an indirect interaction with a
proteinic complex comprised of the shelterin component
TRF2, the helicase BLM, and the enzyme Topoisomerase IIIα
[56]. The reason why telomestatin—or more generally G-
quadruplex ligands—selectively aﬀects tumour cell lines is
yet not fully understood. However, diﬀerences in plasmic
membrane permeability between normal and cancer cells
or in the accessibility of the telomere and in particular
variations in the composition of the shelterin complex have
been proposed; even if the accessibility is identical, one can
imagine that the cellular responses are diﬀerent.
Unexpectedly, only two studies have addressed in detail
the actual binding mode of telomestatin to G-quadruplex
using in silico investigations [57, 58]. This is particularly
surprising, given that there are no structural characteri-
zations of this interaction (NMR, X-ray crystallography)
available to date. These studies support concomitant double
endstacking on quartets, with a preference for the parallel
conformation of the human telomeric quadruplex. This
conclusion is somewhat in contradiction with those of other
studies based on CD spectroscopy [59] or 125I-radioprobing
[60], underlining that further eﬀorts are required to clarify
the interaction mode of telomestatin with quadruplexes.
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Figure 4: Chemical formulae of telomestatin-related macrocycles.
Figure 5: Qualitative in silico superposition of HXDV and a G-
tetrad (extracted from PDB entry: 2A5R); guanine residues appear
in gold, the carbon, nitrogen, oxygen, and hydrogen atoms of
HXDV in grey, blue, red and white, respectively.
Nevertheless, one major concern is that telomestatin is
diﬃcult to synthesise. Despite considerable synthetic eﬀorts
to obtain either fragments of telomestatin or telomestatin-
like arrays of polyoxazoles [61–65], its total synthesis has
been reported only recently [66], and the complexity of
the proposed pathway is incompatible with large-scale
Figure 6: Interaction of TMPyP4 and a G-tetrad (adapted from
PDB entry: 2A5R); guanine residues appear in gold; the carbon,
nitrogen, oxygen, and hydrogen atoms of TMPyP4 appear in grey,
blue, red, and white, respectively.
preparation. This can explain why, whilst the excellence of
telomestatin towards quadruplex-recognition can hardly be
exaggerated, relatively few reports on telomestatin-like com-
pounds have appeared in the literature. Among them, two
hexaoxazole macrocyclic ligands have been independently
reported by Rice et al. [67, 68] and by Shin-ya, Nagasawa
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et al. [69]. The structure of these macrocycles was based
on the dimeric association of two symmetrical trioxazole
moieties through an amino-acid linker, either a valine (for
HXDV, Figure 4) or a protected serine (for S2A2-6OTD,
Figure 4), respectively.
HXDV has been widely investigated and found to
profoundly stabilize the telomeric G-quadruplex structure
by UV-melting assay (ΔTm = 24◦C), without any sig-
nificant binding to duplex DNA [67, 68]. Its association
with a quadruplex-forming sequence mimicking the human
telomeric sequence has recently been confirmed to be based
on external stacking, with occupancy of both external G-
quartets. Interestingly, the high quadruplex selectivity of
HXDV is assumed to originate from its particular telomes-
tatin-like concave shape since the two planes defined by the
trioxazole moieties present an angle of ∼30◦, along with
the disposition of the two amino-acid residues on the same
face of the cycle, thereby optimizing stacking interaction
with quartets (Figure 5) [39]. The biological eﬀects of
HXDV have been investigated on human lymphoblastoma
(RPM1) and murine leukaemia (P388) cell lines, with IC50
values for inhibition of the population doubling in the low
micromolar range (0.4 and 0.5 μM, resp.) [67, 68]. Very
interestingly, it has also been shown recently that HXDV
elicits antiproliferative eﬀect on both telomerase-positive
(HeLa, A875, PC3-1 with IC50 between 0.2 and 0.6 μM) and
telomerase-negative cell lines (like SAOS2 or GM847 with
IC50 between 0.4 and 0.5 μM) mainly through an M-phase
inhibitory eﬀect, thereby contributing to the elucidation
of the actual biological eﬀects of G-quadruplex ligands
[70].
Interestingly, to circumvent the solubility problems,
various HXDV derivatives have been prepared based on
the modification of the nature of the side chain(s), from
two valine residues (for HXDV), to only one valine [71],
one valine and one protected lysine (HXLV-AC) [72], and
two lysine residues (HXDL, Figure 4) [73]. Of all these
derivatives, HXDL appeared as the most promising, whilst
it is not neutral at physiological pH (due to protonation
of both terminal amine groups, whose pKa values are
estimated as 9.9 and 10.5) [74] and the characteristics of its
association with quadruplex are impressive in terms of both
aﬃnity (ΔTm = 49◦C) and selectivity, since only residual
stabilization of salmon testes duplex-DNA is observed. This
gain in eﬃciency is assumed to originate in a higher solubility
and in enhanced interactions with quadruplex-DNA, mixing
both tetrad-stacking and electrostatic interactions.
The success obtained with HXDL was concomitantly—
and independently—confirmed by Nagasawa et al., who
developed a series of G-quadruplex binding macrocyclic
hexaoxazoles (6OTD for 6-Oxazole Telomestatin Deriva-
tives). The very first example of this series, S2A2-6OTD
(Figure 4), [69] was rapidly surpassed by more active
compounds, in which the serine residues of the side chain
were replaced by lysine (L2H2-6OTD, also called HXDL by
Rice et al.) or arginine residues (L2G2-6OTD) [75]. Both
compounds were found to be active in vitro in a range similar
to that of telomestatin, notably via PCR stop assay (IC50
down to 0.64 μM), TRAP assay (IC50 down to 20 nM), and
inhibition of the growth of HeLa cells (IC50 down to 0.5 μM).
Current strategies for improvement include the dimerisation
of the 6OTD scaﬀold (6OTD dimer, Figure 4) [76], using
a bisamide linker between the two 6OTD moieties, which
is long enough to span the thickness of the quadruplex
architecture (∼15 A˚). Unexpectedly the aﬃnity of the dimer
so obtained is not significantly increased as compared with
the corresponding monomer, as judged by FRET-melting
data (ΔTm = 25.1 versus 25.0◦C, resp.) and PCR stop assays
(IC50 = 3.0 versus 2.9 μM, resp.). On the other hand, the
dimer is more selective than the monomer since a ∼10-fold
improvement is obtained when comparing the inhibitory
IC50 values measured by PCR stop assay allowing the authors
to claim a 800-fold selectivity. The fact that the dimer is able
to form a unique 1 : 1 complex with G-quadruplex, as shown
by ESI-MS analysis, added to a proven inability to interact
with duplex-DNA, implies that this dimeric scaﬀold is
optimized for quadruplex recognition. Further improvement
was found by replacing the hexaoxazole scaﬀold by the more
planar heptaoxazole analogue (L1H1-7OTD, Figure 4) [77].
This compound was shown to interact strongly with quadru-
plex DNA (as judged by PCR stop assay, IC50 = 0.67 μM),
with a fair quadruplex-over-duplex DNA selectivity (∼8-
fold). Furthermore, it displays a selective cytotoxicity toward
telomerase-positive cells (HeLa, IC50 = 2.2 μM) as compared
to telomerase-negative cells (Saos-2, IC50 > 30μM). It is
thus highly probable that a dimeric version of the 7OTD
scaﬀold will appear in a near future and that it will help
this scaﬀold to improve its quadruplex-over-duplex DNA
selectivity.
Other series of oxazole-based macrocycles have been
investigated as G-quadruplex binders and notably macrocy-
cles whose structure is based on a trisoxazole [78], trisfuran,
or tetrafuran scaﬀolds [79] (Figure 4). Amino-terminated
chains have been introduced to improve water solubility and
favour electrostatic interactions with DNA (the pKa values
of the amino side chains depicted in Figure 4 standing in
the 8.8–10.7 range) [74], with the chain length finely tuned
to reach the quadruplex grooves. The intrinsic qualities
of these compounds have been evaluated through FRET-
melting assay, and whilst modest results were obtained with
the oxazole-based tripeptide (ΔT1/2 = 6.4◦C), moderate
(ΔT1/2 = 10◦C) to good (ΔT1/2 = 17◦C) results were
obtained with furan-based tri- and tetrapeptides, respec-
tively. Interestingly, when performed with duplex DNA, no
stabilization occurred in any case, thus inferring a high
quadruplex-selectivity of this series of ligands. But a real
breakthrough was achieved in increasing the aromatic sur-
face of the ligands, since stabilizations higher than 30◦C were
obtained with the aminoquinoline-based cyclic oligoamide
depicted in Figure 4 [80, 81]. Once more, this compound
retains a high selectivity for quadruplex DNA, since no
stabilization was detected when a FRET-melting assay was
performed with duplex hairpin-DNA. It is worth noting that
this compound is also able to discriminate various types of
quadruplex DNA (human telomeric versus oncogenic c-kit),
thus opening perspectives for discovery of a novel generation
of selective and specific G-quadruplex ligands. Additionally,
the very attractive in vitro biophysical results were also
6 Journal of Nucleic Acids
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complemented by the low general cytotoxicity of the cyclic
oligopeptides.
Despite the real viability of the neutral macrocyclic scaf-
fold for G-quadruplex recognition, the equilibrium between
hydrosolubility and activity is diﬃcult to achieve. One
improvement has been the introduction of amino side chains
that increase water-solubility and electrostatic attraction
with the DNA target without altering the duplex-versus-
quadruplex selectivity of the ligand, which relies on the shape
and rigidity of the polyhetroaryl cyclic scaﬀold itself. Such
molecular designs have thus to be further investigated, in
order to gain more insights in terms of bioavailability and
selective cytotoxicity.
3. Porphyrin- (TMPyP4-) Like Macrocycles
Along with neutral and cationic cyclic polyheteroarenes,
cationic porphyrins are probably the most widely used
macrocyclic G-quadruplex ligands. TMPyP4 (for 5,10,15,
20-tetra(N-methyl-4-pyridyl)porphyrin) [34, 35] is a rep-
resentative example of this family of ligands (Figures 2 and
6) [39]. The ability of TMPyP4 to interact with DNA was
first mentioned 30 years ago [82–84] whilst its use as a
G-quadruplex ligand was reported for the first time twenty
years later [34, 35, 85]. Since these seminal reports, this
tetracationic porphyrin has been extensively studied: it has
demonstrated a high aﬃnity for G-quadruplex DNA (as
monitored by FRET-melting assay, ΔT1/2 = 17◦C) [86], but
with low selectivity [86–91]. TMPyP4 has been particularly
used as a tool to investigate the possibility of downregulating
the expression of genes due to quadruplex formation
or induction (like c-myc [92–100], RET [54], HIF-1α
[101], VEGF [50, 102, 103], Bcl-2 [53, 104, 105], KRAS
[106], PDGF-A [107], c-kit [108], and even hTERT genes
[51]). The biological behaviour of TMPyP4 has also been
investigated in vitro against a broad variety of tumor cell
lines (with IC50 between 23 and 310 μM), including human
pancreatic [40], breast [85], and prostate carcinomas [85],
lymphoma [85], retinoblastoma [109], leukaemia [110] and
human gastrointestinal stromal tumor [108] cell lines, as well
as telomerase-transformed SW39 [45], ALT-transformed
SW26 [45], transformed human breast [85] and HeLa
cell lines [111]. TMPyP4 has also been tested on normal
cell lines (human fibroblast and breast cell lines) [85], in
which it demonstrated moderate to acute cytotoxicity (IC50
down to 13 μM). It has also been used as an in vitro tool
for more prospective and fundamental studies [112–115],
sometimes exhibiting some unexpected behaviour, including
quadruplex-unfolding activity on both quadruplex-
forming DNA (d(CGG) repeats [116], or antithrombin
Journal of Nucleic Acids 7
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Figure 10: Qualitative in silico superposition of 3,4-TMPyPz (a) and corrole (b) and a G-tetrad (extracted from PDB entry: 2A5R); guanine
residues appear in gold; the carbon, nitrogen, oxygen, and hydrogen atoms of the ligands in grey, blue, red, and white, respectively.
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aptamer) [117] and RNA sequences (r(CGG) repeats)
[118].
Interestingly, despite the fact that it was quickly acknowl-
edged that TMPyP4 has poor selectivity for quadruplex
structures [86–91], this ligand is still the focus of an intense
research interest. Notably, a lot of structural studies are
currently undertaken to investigate its binding mode with
quadruplex DNA; interestingly, TMPyP4 displays various
quadruplex-interactions, ranging from intercalation between
adjacent G-quartets (as suggested via Raman spectroscopy
studies) [119] to the more expected stacking on the external
G-quartet (demonstrated by NMR studies) [120], passing
by a mode totally devoid of direct contacts with G-quartets
(shown by X-ray analysis of obtained crystal structures)
[121], without excluding the possibility of combining several
binding modes during a single recognition process (vide
infra). These eﬀorts are also currently completed by investi-
gations dedicated to the understanding of the nature of the
interaction between TMPyP4 and G-quadruplex, either in
silico [100, 122, 123] or via established biophysical methods,
UV-Vis [105], steady-state or time-resolved fluorescence
[124–127], CD [128–130] or Raman spectroscopies [119], as
well as ITC [99, 131–133], ESI-MS [134], DSC [135], SPR
[90], or even HPLC methods [136], on a broad variety of
quadruplex architectures, for example, telomeric [90, 119,
125, 127, 128, 130–133, 135], c-myc [99], c-kit [108], Bcl-
2 [105, 134], TBA [136], the bimolecular (G4T4G4)2 [124],
or the tetramolecular (TG4T)4 quadruplexes [126], and even
G-wires [129]. Nevertheless, it is worth pointing out that a
vast majority of these studies have been carried out in in
vitro conditions that have to be considered as “dilute” as
compared to the crowded environment within a living cell
(due to the presence of naturally occurring proteins, nucleic
acids, sugars, etc.). Interestingly, when the conditions are
artificially crowded (using molecular crowding agents such
as ethylene glycol [130] or poly(ethylene glycol) [125, 132],
TMPyP4 displays a higher aﬃnity (for quadruplex-DNA)
[125, 130] and selectivity (with regard to duplex DNA)
[132] than in dilute conditions, on the basis of a diﬀerent
recognition process (the crowded conditions influencing
both the quadruplex DNA structures and the TMPyP4
stacking interactions, becoming multiple but stepwise [125,
132]). Given that crowded conditions are more biologically
relevant, these results indicate that TMPyP4 may be more
selective than anticipated in cells, and these observations will
certainly revitalize TMPyP4-related researches.
Thus, the current status of TMPyP4 is the opposite
of telomestatin; it is both commercially and synthetically
accessible and its interaction with quadruplexes, although
multiple, is fully characterized. Finally, the simple geometric
comparison allowed by the overlaps shown in Figures 3
and 6 strongly suggests that the tetrapyrrolic macrocycle is
much less suitable than the octacyclic ring for optimizing
aromatic-aromatic interactions with a G-quartet. In conclu-
sion, although TMPyP4 remains an interesting tool that has
contributed to the understanding of the ligand–quadruplex
interactions and to their complexity, its biological use for
probing the involvement of quadruplex in biological assays
is questionable.
With an inner cavity particularly suited to coordination
of a metal, TMPyP4 (and other porphyrins, vide infra)
has been also widely exploited to form metal complexes.
Given the well-known modulation of DNA association by
metallation, this modification was thus performed in order
to improve the DNA recognition [82–84]. TMPyP4 has now
been used to prepare Pt(II), Cu(II), In(III), Zn(II), Co(II),
Fe(III), Ni(II), Mn(III), Mg(II), and Pd(II) complexes [34,
137–142]. Among them, Mn-TMPyP4 (Figure 7) deserves
particular attention since it showed a strong improvement
in terms of quadruplex-versus-duplex selectivity.
The porphyrin core, as clearly demonstrated with
TMPyP4, has been extensively explored as a macrocyclic
scaﬀold for the design of G-quadruplex ligands. Among the
numerous examples that have been reported, either as metal
free or in a complexed state, the most interesting ligands are
presented in Figure 7. Even if the methods for analyzing G-
quadruplex aﬃnity and selectivity are not yet standardised,
the nature of the side arms that surround the porphyrin core
is unmistakably crucial. Indeed, while the above mentioned
Mn-TMPyP4 was able to interact with G-quadruplex 10
times faster than with duplex DNA, a 10,000-fold diﬀerence
was obtained by moving the N-methylpyridinium moieties
from the close vicinity of the porphyrin core to the termini
of flexible arms [143]. This modification is assumed to
greatly improve the electrostatic interaction with quadruplex
grooves, while impeding intercalation into duplex DNA.
This kinetic diﬀerence was evaluated through biosensor-
surface plasmon resonance (SPR) measurements. The SPR
technique, based on the use of surface-immobilized oligonu-
cleotides, enables a quantitative analysis of the binding
parameters, that is, thermodynamic (equilibrium constant,
Gibbs energy of binding, and stoichiometry) and kinetic
(kon/koﬀ) parameters of the interaction of small molecules
with the target DNA [90, 144]. In the present case, the
aﬃnity constant determined with duplex DNA lies in the
104 M−1 range, reaching up to 108 M−1 with quadruplex-
DNA. Even if more modest, similar observations were made
with TQMP, a porphyrin in which N-methylpyridinium
substituents were replaced by (trimethylammonium)methyl-
phenol arms (Figure 7) [91]. In this case, an ∼100-fold
diﬀerence in the kinetics of the association with duplex
(104 M−1 · s−1 range) and quadruplex DNA (106 M−1 · s−1
range) was obtained. Finally, knowing that the nature and
number of the surrounding side arms can be finely tuned
in the case of TMPyP4 [145, 146], interesting perspectives
exist to modify porphyrin-based G-quadruplex ligands in
this way. It is, however, worth noting that the equilibrium
between aﬃnity and selectivity is diﬃcult to access with
the TMPyP4 scaﬀold, as demonstrated by a recent study in
which a TMPyP4-related compound was included in a high-
order supramolecular architecture (ruthenium coordination
cubes) [147], on the basis of the elegant idea to use the
metal itself to build the macrocyclic scaﬀold [148]. These
cubic complexes were indeed shown to strongly bind not
only quadruplex-DNA but also duplex-DNA, despite their
peculiar molecular volume. This lack of selectivity may
originate in their highly cationic nature (eight positive
charges).
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Figure 11: Chemical formulae of Hemin (a) and NMM (b).
Figure 12: Qualitative in silico superposition of NMM and a G-
tetrad (extracted from PDB entry: 2A5R); guanine residues appear
in gold; the carbon, nitrogen, oxygen, and hydrogen atoms of NMM
in grey, blue, red, and white, respectively.
A large number of structural analogues of TMPyP4 have
been recently described in the literature, diﬀering notably
by the nature of the side-arms (N-methylpyridinium groups
have, for example, been replaced by N-propylpyridinium
[126], N-methylquinolinium [149], and phenyl groups with
short [150] or long aminoalkyl arms [151], and even
endowed with fluorescent reporters) [152]. The extensive
family of ring-size analogues of the 16-membered por-
phyrins are exemplified in Figure 8, including the 15-
membered corrole, 16-membered phthalocyanine or por-
phyrazine, and the 19-membered sapphyrin, which have
all been employed for the construction of G-quadruplex
ligands.
Corroles are tetrapyrrolic macrocyclic structures, lack-
ing one bridging sp2 carbon with respect to porphyrins.
Interestingly, the resulting TMPyP4 analogue, which is
substituted with N-methylpyridium groups (Figure 9) [153],
is only trisubstituted, with a peculiar spatial disposition
of pyridinium moieties relative to each other (Figure 10)
[39]. This corrole eﬃciently stabilizes quadruplex DNA,
as judged from CD-melting experiments (Tm increase of
36◦C), with a fair selectivity, judged by SPR measurements
(aﬃnity constants in the range of 105 and 106 M−1 for
duplex- and quadruplex-DNA, resp.). Copper corroles have
also been studied and proved to be good stabilizing agents
for quadruplexes formed from sequences of both the human
telomere and the c-myc promoter [154]. Porphyrazine,
the polyaza tetra(pyrrolopyridine) analogue of porphyrin
(Figures 8 and 9), has also been widely used in the design of
G-quadruplex ligands, because of its steric properties (close
to those of the porphyrin), but also because its synthesis
opens novel perspectives for structural diversity. It enables,
for example, to fuse the pyridinium moieties with the cyclic
scaﬀold, thereby leading to a flat, electron-deficient and
structurally frozen macrocycle, with an excellent overlap of
a G-tetrad (Figure 10) [39]. 3,4-TMPyPz, used either as
metal-free or as Zn complex, shows a high aﬃnity and
selectivity for quadruplex DNA, as demonstrated by UV-
Vis and SPR experiments (aﬃnity constants in the range
of 106 M−1 for quadruplex DNA and <105 for duplex-
DNA), with a refined binding mode, since a unique binding
site was determined using both of these techniques [155].
It is worth noting that 3,4-TMPyPz has also been used
as a tool to investigate the role of G-quadruplex ligands
in a totally telomere-independent mechanism, that is, an
innovative gene-silencing strategy based on the control by
a G-quadruplex ligand of the dicing of quadruplex-forming
short hairpin RNAs that actively participate to the RNA
interference (RNAi) pathway [156].
Phthalocyanines are structurally close to porphyrazines,
with the pyridine rings that compose the porphyrazine
scaﬀold replaced by benzene rings. The zinc phthalocyanine
complex ZnPc (Figure 9) [157, 158] carries the classical
amino side chains in the close vicinity of the macrocyclic
scaﬀold. The results are interesting, since they demonstrate
that a highly charged compound (up to 8 positive charges),
whilst presenting an expected high degree of quadruplex
aﬃnity, can concomitantly retain a satisfactory level of
selectivity (on the basis of SPR and CD-melting data),
the diﬀerence in kinetic parameters with duplex-versus-
quadruplex DNA being in the range of one order of
magnitude. When the aminoalkyl side arms of ZnPc are
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Figure 13: Chemical formulae of nonplanar macrocyclic G-quadruplex ligands: BOQ1 (a), BisA (b), and the neomycin-capped scaﬀold
NCQ (c).
replaced by guanidinium moieties, the corresponding Zn-
DIGP (for tetrakis-(diisopropylguanidinio) zinc phthalo-
cyanine, Figure 9) elicits quite exceptional properties, both
in terms of quadruplex aﬃnity (Kd < 2 nM for c-myc
quadruplex) and quadruplex-versus-duplex DNA selectivity
(Zn-DIGP displays a 5000-fold higher aﬃnity for c-myc
quadruplex than for calf thymus DNA). In addition, Zn-
DIGP exhibits “turn-on” fluorescent properties, making it a
particularly interesting quadruplex-selective dye [159]. Very
recent studies have substantiated the interest in this series
of molecules, confirming their good cellular uptake and
inhibition of promoter-quadruplex-mediated genes (KRAS)
[160].
The expanded diselenosapphyrin Se2SAP (Figure 9) rep-
resents a novel class of chemically challenging compounds
but with a very interesting ability to interact only with its
preferential target, the oncogenic c-myc-derived quadruplex
[52, 59]. Indeed, Se2SAP discerns, firstly, among the DNAs
of various nature (duplex and quadruplex DNA, with a
selectivity factor of ∼600 as judged by a competitive Taq
polymerase assay), and secondly, among quadruplex DNA
of various structures (Se2SAP binds specifically c-myc, as
compared to human telomeric quadruplex, but displays also
a higher aﬃnity for the quadruplex found in the promoter
region of VEGF) [102]. The substitution of nitrogen by
selenium atoms in the backbone of the ligand was motivated
by the decrease of the known photocytotoxicity of the
porphyrins, as confirmed by the low general cytotoxicity of
Se2SAP in HeLa cells (no eﬀect at 200 μM dose). One major
drawback to the use of Se2SAP in cells stands in its limited
bioavailability, which remains to be improved for further
biological investigations.
A further noteworthy family of porphyrins is hemin
and related compounds. Hemin, also known as Fe(III)-
protoporphyrin IX (Figure 11), is the oxidized version of
heme (Fe(II)-protoporphyrin IX), widely known as a cofac-
tor of hemoglobin (and myoglobin) that actively participates
in the reversible binding of dioxygen. Since the pioneering
work of Sen et al. [161–165], hemin is known to bind
tightly to quadruplex architecture; however, hemin has not
been investigated as a G-quadruplex ligand per se, but
has been thoroughly investigated for its DNAzyme activity
when bound to quadruplex. Indeed, the hemin/quadruplex
complex acquires the ability to catalyze the H2O2-mediated
oxidation of precursors such as ABTS (2,2′-azino-bis(3-
ethylbenzothiozoline-6-sulfonic acid) [161–165], luminol
[166–168], or TMB (3,3′,5,5′-tetramethylbenzidine) [169,
170], therefore causing an easily detectable color change.
This particular activity has found numerous applications,
including the detection of telomerase activity [167, 168],
single-stranded DNA [171], SNP (single-nucleotide poly-
morphism) [172], DNA [173] and DNA analytes [174],
proteins (like nucleolin [175], lysozyme [176], or thrombin
[177]), various cations (such as Cu2+ [169], Hg2+ [178,
179], Pb2+ [180], or K+) [181], or enzyme cofactors (like
L-histidine) [180], as well as a use for constructing DNA
logic gates [182, 183], and it has been also implied in
the development of novel in vitro assays for screening G-
quadruplex ligands [184, 185].
A hemin-related porphyrin, NMM (or N-methyl meso-
porphyrin IX) has also been thoroughly investigated for
its ability to interact with G-quadruplex. NMM (Figure 11)
is interesting as the unique representative of the nega-
tively charged macrocyclic G-quadruplex ligands (its two
carboxylic groups being deprotonated at physiological pH)
[74, 186–188]. NMM was initially studied since it behaves
as stable transition-state analogue for ferrochelatase enzyme,
which catalyzes the insertion of Fe2+ ions into protopor-
phyrin in the final step of the heme biosynthesis [161–165].
Whilst NMM became rapidly known as highly quadruplex
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selective [87, 189], it was only sparingly studied due to a
moderate aﬃnity for its DNA target, despite an excellent
overlap with the G-tetrad (Figure 12). However, in recent
studies in yeast, it has shown a very interesting ability to
control the regulation of genes in direct connection with
the probability of quadruplex formation in their promoters
[190, 191]. Additionally, given that the eﬀect of NMM is
felt at both telomeres and loci throughout the genome, this
study provides novel lines of evidence of the possible in
vivo roles of G-quadruplexes. Finally, NMM has also been
used as a novel tool for isolating G-quadruplex DNA from a
mixture of nucleic acids derived from in vivo sources, via its
grafting on a sepharose resin, thus oﬀering an innovative way
to determine whether or not the in silico detected putative
quadruplex-forming sequences (QFSs) [192–194] exist in the
cellular context as quadruplex DNA [195].
4. Polyammonium Cyclophane-Type
Macrocycles
As compared to the telomestatin, porphyrins, and related
compounds, polyammonium cyclophane-type macrocycles
have not been extensively studied as G-quadruplex ligands.
Mainly two types of cyclophane-like macrocycles have been
studied for their interaction with quadruplexes: the cyclo-
bisintercalator family (CBI, Figure 13) and the neomycin-
capped aromatic platforms (exemplified by NCQ, Figure 13).
The CBI macrocycles contain two flat aromatic units,
usually derived from simple intercalators linked together by
polyamine chains. This particular scaﬀold is highly soluble
at physiological pH thanks to protonation of the four
benzylic nitrogen atoms of the linkers [196]. With regard
to DNA binding, the CBIs present unique features that are
(i) a strong association with DNA bases via aromatic π-π
interactions and (ii) a very low aﬃnity for duplex-DNA.
This family of compounds has already been studied for
its recognition of various unusual DNA structures, mainly
mismatch-containing DNA [197–200], abasic sites [201],
and trinucleotide repeats [202]. However, only two members
of this family, namely, BOQ1 (for Bis-Ortho-Quinacridine,
Figure 13) [203–205] and BisA (for Bis-Acridine, Figure 13),
[206] have been already evaluated for their ability to interact
with quadruplex-DNA.
BisA and more particularly BOQ1 display promising G-
quadruplex-binding properties. Both compounds are com-
posed of two large polycyclic aromatic moieties, namely,
acridine [207–209] or quinacridine [210–212], that enable
eﬃcient π-stacking interactions with nucleic bases in partic-
ular guanines [213]. These dimeric macrocycles were found
to bind much better to quadruplexes than their planar
monomeric acyclic counterparts [203–206]. This strong
association has been demonstrated by numerous techniques,
including FRET-melting assay, SPR, and equilibrium dialysis:
BOQ1 and BisA eﬃciently induce thermal stabilization of the
human telomeric quadruplex (ΔT1/2 = 28 and 15◦C, resp.)
displaying high aﬃnity for this target (Ka = 1.2 × 107 M−1
for BOQ1 measured by SPR and 1.1 × 105 M−1 for BisA,
estimated by dialysis) [203–206]. The diﬀerence between the
two compounds clearly demonstrates the importance of the
size of the aromatic unit in the binding interaction with the
quadruplex structure.
Most interestingly the two compounds exhibit a high
selectivity for quadruplex over duplex DNA attributed to
their particular topology. CBIs are clearly distinct from the
planar rigid macrocycles mentioned precedently since they
exist in a semiclosed conformation with the two aromatic
units facing each other in more or less parallel planes (Figures
13 and 14) [39]. This particular nonplanar conformation
impedes binding to duplex-DNA, both for steric reasons and
because the length of the linkers does not enable bisinterca-
lation between contiguous base pairs due to the neighbour-
exclusion principle [214, 215]. In the case of BOQ1, this
particular topology was found both in the free state (Figures
14(a)–14(c)) and in the complex formed with the human
telomeric quadruplex (Figure 14(d)) [205], meaning that
there is little conformational change upon binding. This
would suggest that the ligand is already preorganized to fit
into the quadruplex target resulting in a gain in the binding
entropy. In addition, the modelling studies performed
both with the telomeric and with the c-myc quadruplex
demonstrate that the semiclosed conformation of BOQ1
enables interaction via a mixed binding mode, combining G-
quartet and loop (Figure 14(d), c-myc not shown) [205]. In
fact, careful examination of this complex strongly suggests
the occurrence of electrostatic and H-bonding interactions
between the linkers and the loop backbone (Figure 14(d)).
The second category of polyammonium cyclophane-type
macrocycles, namely, the neomycin-capped macrocycles was
developed with the goal to validate the ditopic interactive
design. To this aim three aromatic platforms (acridine,
phenanthroline, and quinacridine) able to stack on a G-
quartet were combined with a well-known loop-binding
motif, that is, the aminoglycoside neomycin. The most
active prototype of this series is the quinacridine derivative
NCQ shown in Figure 13 [216, 217]. This ligand that has
a high degree of molecular flexibility is a potent binder of
the telomeric quadruplex as shown by the FRET melting
assay (ΔT1/2 = 15◦C) whereas it elicits a poor aﬃnity for
duplex-DNA. Most importantly NCQ elicits a high degree
of selectivity for looped quadruplex (i.e., intramolecular
telomeric quadruplex), compared with the tetramolecular
quadruplex lacking the loop motifs. The preference for
intramolecular over tetramolecular quadruplexes confirms
the potential of the multitopic approach and altogether
this work proposes a new innovative design for achiev-
ing intra-quadruplex selectivity. Subsequent studies have
since then fully supported this approach using various G-
quadruplex recognition scaﬀolds, including a macrocyclic
oxazole-based tripeptide [218] or a small-molecule lig-
and (acridine) [219] equipped with loop and/or groove
recognition elements like carbohydrates [218] or peptides
[219].
In conclusion, polyammonium cyclophane-type macro-
cycles have been only sparingly studied as G-quadruplex
ligands. They are able to establish various types of interaction
with their DNA target, thereby opening the innovative
perspective of a selective interaction with quadruplex DNA
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Figure 14: Structure of BOQ1 (a), side (b), and front views (c) of the lowest-energy conformation during the molecular dynamic simulation
(see [39]) and modelled interaction between BOQ1 and the human telomeric quadruplex ((d), see [205]); guanine residues appear in gold;
the carbon, nitrogen, oxygen, and hydrogen atoms appear in grey, blue, red, and white, respectively.
as a function of the nature of the quadruplex structure itself.
This intra-quadruplex selectivity, motivated by the putative
presence of quadruplexes at various genomic localizations
(vide supra), is one of the major issues that will have to
be addressed in the near future. The results previously
obtained with CBIs and presented herein, although limited
to a few examples, are promising. On this solid basis, an
extensive study of binding of CBIs to G-quadruplex has
been undertaken which is further reported in the companion
paper (“One Ring to Bind ThemAll”—Part II, by A. Granzhan
et al.), a research article in the present issue.
5. Conclusion
Macrocyclic scaﬀolds are particularly attractive for designing
selective G-quadruplex ligands essentially for the two fol-
lowing reasons: on one hand, they show a poor aﬃnity for
the “standard” B-DNA conformation, due to their sterically
diﬃcult intercalation between the base pairs of the double
helix; on the other hand, in contrast, they fit nicely with
the external G-quartets of quadruplexes that constitute
accessible planar sites of large aromatic area. Although
synthetic accesses to macrocycles are often diﬃcult, this
chemical class is nevertheless a fascinating tool that can be
chemically engineered to generate new biological properties.
The few macrocyclic families depicted herein have only
begun to mine this incredible potential and we hope that the
present article will be helpful to understand what the crucial
guidelines are to control their eﬃciencies and selectivities for
recognizing quadruplexes.
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